2024, 4+, Analisi statistiche e metanalisi, Anno, Autore, Damuzzo, Del Bono, Gasperoni, Impact factor, Messori, Ossato, Pubblicazioni, Topic
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free Survival
2023, 4+, Analisi statistiche e metanalisi, Anno, Autore, Cancanelli, Chiumente, Damuzzo, Di Spazio, Impact factor, Mengato, Messori, Ossato, Pubblicazioni, Rivano, Topic
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses
1-2, 2022, Analisi statistiche e metanalisi, Autore, Cancanelli, Chiumente, Damuzzo, Impact factor, Mengato, Messori, Ossato, Pubblicazioni, Rivano, Topic
The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.
1-2, 2021, Agnoletto, Anno, Autore, Cammalleri, Cancanelli, Chiumente, Costantino, Damuzzo, Impact factor, Mengato, Michielan, Milani, Pubblicazioni, Rampazzo, Rivano, Sartori, Studi real world, Topic